Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03773237 · ClinicalTrials.gov registry record · NA
Intralipid Versus SMOFlipid in HPN Patients
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT03773237: Completed NA study, sponsored by Mayo Clinic.
NCT03773237 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03773237, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
This study will randomize all patients who are new to the Mayo Clinic HPN team to either standard lipid emulsion (Intralipid) or SMOFLipid.
Interventions
- DIETARY_SUPPLEMENT Intralipid
- DIETARY_SUPPLEMENT SMOFLipid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2018-12-31 |
| Est. Completion | 2024-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03773237
The ClinicalTrials.gov registry entry for NCT03773237 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Intralipid is the first listed.
NCT03773237 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03773237 about?
NCT03773237 is a clinical study titled "Intralipid Versus SMOFlipid in HPN Patients". This study will randomize all patients who are new to the Mayo Clinic HPN team to either standard lipid emulsion (Intralipid) or SMOFLipid.
What is the current status of trial NCT03773237?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2018-12-31. Estimated completion is 2024-10-01.
What interventions are being tested in trial NCT03773237?
The interventions under investigation include: Intralipid (DIETARY_SUPPLEMENT), SMOFLipid (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03773237?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.